Pharmaceutical News

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (Nasdaq: DXCM), the global leader in glucose biosensing, announced today through ongoing quality and accounting reviews it recently identified certain lots of Dexcom G7 sensors originally designated as scrap and intended for destruction were stolen during the destruction process, then sold by third parties. Scrapping limited amounts of sensors that do not meet Dexcom standards is a routine part of the company’s quality control process. Sensors identified...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and debilitating neuromuscular diseases by applying its leading platform in myostatin biology to advance musculoskeletal health, today announced that management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 9, 2026 at 10:...

SANTA CLARA, Calif.--(BUSINESS WIRE)--ValGenesis, Inc., the market leader in digital validation, will host the next event in its global ValConnect Innovation Day series on June 2 in North Carolina’s Research Triangle Park. Hosted in partnership with Sequence Inc., at the company’s RTP headquarters, the one-day program will bring together life sciences professionals to explore AI-powered validation, digital transformation, and the evolving role of AI in modernizing validation processes across re...

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. and its subsidiary, Biotheranostics, Inc., today announced new data demonstrating how the Breast Cancer Index® (BCI™) Test results influence extended endocrine therapy decisions for patients with early-stage, hormone receptor-positive (HR+) breast cancer. According to the latest analysis, physician recommendations for extended endocrine therapy increased by more than 30% among patients identified by the BCI Test as likely to benefit, while reco...

BERKELEY, Calif.--(BUSINESS WIRE)--The dataset is now available to the research community to accelerate the development of improved models for protein stability prediction....

FARMINGTON HILLS, Mich.--(BUSINESS WIRE)--LSPedia (the “Company”), a leading provider of mission-critical compliance, traceability, and supply chain software to the pharmaceutical industry, today announced a strategic growth investment from Bregal Sagemount (“Sagemount”), a leading growth-focused private equity firm, through its Basecamp fund. The investment will support LSPedia’s continued product innovation, customer expansion, and the acceleration of the Company’s global growth strategy. Fou...

RAVENSBURG, Germany--(BUSINESS WIRE)--Vetter, a leading Contract Development and Manufacturing Organization (CDMO), has been named a Best Managed Company for the seventh year in a row. The family-owned business was the only company in this year’s competition to be newly awarded Platinum status. The prestigious prize is awarded by Deloitte Private, UBS, Frankfurter Allgemeine Zeitung and the Bundesverband der Deutschen Industrie e.V. (Federation of German Industries, BDI) to companies for outsta...

CINCINNATI--(BUSINESS WIRE)--LIB Therapeutics Inc. (LIB), a privately-held, biopharmaceutical company with a recently approved novel, monthly, small-dose, third-generation PCSK9 inhibitor, LEROCHOL® (lerodalcibep-liga), today announced results from two oral and two poster presentations at the European Atherosclerosis Society meeting, held in Athens, Greece, May 24-26, 2026. Oral Presentations, May 25, 2026: The Long-Term Efficacy and Safety of Lerodalcibep in Homozygous Familial Hypercholestero...

BEIJING--(BUSINESS WIRE)--Biocytogen today announced the launch of RenSuper Workstation, a next-generation AI-powered antibody discovery platform providing off-the-shelf access to a large-scale, experimentally validated library of fully human therapeutic antibody sequences, together with the RenSuper High-Throughput Antibody Manufacturing Automation Center, a fully automated infrastructure designed to accelerate antibody validation and production. Built on Biocytogen’s proprietary RenMice® plat...

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the release of a new multi-attribute method (MAM) workflow designed to help pharmaceutical and biopharmaceutical quality control (QC) laboratories implement liquid chromatography high-resolution mass spectrometry (LC/HRMS) in routine, regulated testing environments. The Agilent MAM solution brings together software, instrumentation, columns, consumables and standards to address practical and operational ba...